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Abstract 
Major Depressive disorder (MDD) is the most severe depression type and one of leading 
causes of morbidity worldwide. Animal models are widely used to understand MDD etiology, 
pathogenesis and treatment, but the efficacy of this research for patients has barely been 
systematically evaluated. Such evaluation is important given the resource consumption and 
ethical concerns incurred by animal use.  
We used the citation tracking facilities within Web of Science and Scopus to locate 
citations of original research papers on rats related to MDD published prior to 2013- to allow 
adequate time for citations- identified in PubMed and Scopus by relevant search terms. 
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Resulting citations were thematically coded in eight categories, and descriptive statistics were 
calculated. 
178 publications describing relevant rat studies were identified. They were cited 8,712 
times. More than half (4,633) of their citations were by other animal studies. 794 (less than 
10%) were by human medical papers. 
Citation analysis indicates that rat model research has contributed very little to the 
contemporary clinical understanding of MDD. This suggests a misuse of limited funding hence 
supporting a change in allocation of Research & Development funds targeting this disorder 
maximizing benefits for patients. 
Keywords: Major Depressive Disorder, animal models, animal use alternatives, citation 
analysis 
Introduction 
Depression is the leading cause of disability worldwide (World Health Organization – 
WHO, 2019). Nowadays it is judged to affect more than 320 million people of all ages and 
genders (Vos et al, 2016), even though it is more frequent in women than man (Ferrari et al., 
2013). 
Currently, and according to DSM-5 (American Psychiatric Association – APA, 2013), 
there are eight main forms of depression: Major Depressive Disorder (MDD), Persistent 
Depressive Disorder, Dysphoric Disorder and Disruptive Mood Dysregulation Disorder, 
Substance/Medication-Induced Depressive Disorder, Depressive Disorder Due to Another 
Medical Condition, Other Specified Depressive Disorder. MDD is the most severe, prevalent 
and disabling depression type (Malhi & Mann, 2018). It is characterized by a persistent 
depressed mood or loss of pleasure, along with four out of the following symptoms: significant 
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weight loss or gain; insomnia or hypersomnia; psychomotor agitation or retardation; fatigue or 
loss of energy; feelings of worthlessness or excessive or inappropriate guilt; diminished ability 
to think, concentrate or make decisions; recurrent thoughts of death (APA, 2013). For MDD to 
be diagnosed, the patient needs to fulfil five diagnostic criteria out of a pool of nine, which 
means that the same disorder may present differently in different subjects (Kaufman, 2018). 
The variety of both symptoms biomarkers has led to the recent suggestion that there might be 
several subtypes of MDD (Beijers et al., 2019). 
MDD aetiology is not completely understood yet. Most authors agree that there is a 
combination of biological and environmental factors that determine the triggering of the 
disorder (Mandelli & Serretti, 2013). Biological factors to take into account include genes, 
neurotransmitters and hormones, while environmental factors include childhood trauma, 
stressful life events, sexual abuse, low educational attainment and differences in personality 
traits. 
Evidence suggests that there are genetic factors involved, but even though more than 100 
candidate genes have been investigated, a clear connection between specific genes and MDD 
has not yet been established (Shadrina et al., 2018). Furthermore, studies suggest that variations 
in different genes, each with a minor effect, combine to increase the risk of developing this 
disorder (Wray et al., 2018). Most studies suggest that MDD patients have imbalanced brain 
chemistry at neurotransmitters level (Beijers et al., 2019). Amongst those, the majority of the 
studies indicate dopamine, norepinephrine and serotonin as the most implicated in MDD 
aetiology (Belujon & Grace, 2017). Others stress the involvement of glutamate (Réus et al., 
2018). Nonetheless, some studies find no differences in neurotransmitters between MDD 
patients and healthy controls (for a review see Beijers et al., 2019). Similarly, it is widely 
accepted that hormones play a role in MDD aetiology (Druzhkova et al., 2019) but there is no 
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clear-cut connection between a specific hormone secretion and MDD. For example, 
Asadikaram et al. (2019) found differences between MDD patients and healthy controls in 
hormone levels of adrenocorticotropic hormone, testosterone, thyroid‐stimulating hormone, 
free thyroxine index and cortisol/dehydroepiandrosterone sulfate (DHEA‐S), while others 
consider vasopressin and oxytocin to play a pivotal role in MDD aetiology (for a review see 
Iovino et al., 2018). 
Recent studies also suggest that there is a link between inflammation and MDD, 
suggesting that MDD has an inflammatory subtype (Beijers et al., 2019), but the claims that 
inflammation has a role in aetiology of MDD are still being disputed (Miller, 2018). The same 
happens with changes in gut microbiome in MDD patients (Winter et al., 2018). While the link 
between gut microbiome and depression is well documented, the question of the causality in 
the connection between the two remains to be robustly answered (Winter et al., 2018). It is 
important to mention that these patterns may be true for all biological changes found in MDD 
patients. It is almost impossible to determine if the biological changes caused MDD or if MDD 
caused the biological changes. Conversely, most environmental factors involved in MDD are 
definitely a primary cause. In this regard, the big unanswered question that remains is why does 
the same life event trigger MDD in one person and not in another.  
Amongst the most documented environmental factors linked to MDD are childhood 
traumas, which also cause biological changes in the brain of MDD patients (Yu et al., 2019), 
stressful life events, sexual abuse, low educational attainment (Peyrot et al., 2013) and 
personality traits (Bensaeed et al., 2014). Other disorders and traits are also strong predictors 
for MDD. For example, a big longitudinal study showed that people who present anxiety traits 
in their twenties are more prone to develop MDD in their thirties (Gustavson et al., 2018). Also 
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Parkinsons’, Migrains’, Alzheimers’ patients, amongst others, have high prevalence of MDD 
(Ketharanathan et al., 2014; Muneer et al., 2018; Tao et al., 2019). 
It is not always possible to determine a proximal cause. MDD may have seasonal or peri-
partum onset, as well as being induced by other disorders (e.g., Parkinson) or substance 
ingestion, but it can also emerge without an obvious reason (APA, 2013). 
MDD pathogenesis is as diverse as its aetiology. Even though there are several different 
treatment courses available (for a review see for example Pandarakalam, 2018), 50 to 60% of 
patients develop treatment resistant depression, i.e., do not enter remission even after trying 
different courses of treatment (Kraus et al., 2019), and only 52% of patients achieve a full 
recovery (Novick et al., 2017).   
Due to its complexity, MDD is particularly hard to study, but its severity, prevalence and 
significant economic burden make it a moral and social imperative to keep investing this 
research field. Yet, its research funding has been scarce when compared to other disorders (e.g. 
cancer) (Ledford, 2014).  
Randomised controlled trials (RCTs) are considered to be the gold standard for empirical 
research (Hariton & Locascio, 2018), namely in MDD’s potential treatments and interventions 
(Monsour et al., 2019) but they are unsuitable for all purposes. Some authors consider 
observational longitudinal studies to be more useful in understanding the aetiology and 
pathogenesis of human disorders (Frieden, 2017) pointing out that they also overcome ethical 
and practical limitations of RCTs such as the insufficient study duration or the disregard of 
unpredictable variables that affect patients in their daily lives (Song & Chung, 2010). Others 
stress the importance of basic and applied research aiming to understand MDD’s mechanisms 
in a controlled environment (e.g., Papassotiropoulos & de Quervain, 2015). 
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In this regard, advanced magnetic resonance imaging techniques used in patients and 
healthy controls can be a powerful tool regarding the physiological and metabolic 
characterization of brain tissue, in the same way that single photon emission computed 
tomography and positron emission tomography imaging modalities provide valuable data on 
brain function and activity (Tsougos et al., 2019).  
Post-mortem studies as well as cell-based disease modelling are another valuable set of 
tools in understanding the biology of psychiatric disorders. As cellular biology techniques 
evolve new ways to generate and preserve human cells in vitro emerge (e.g. induced pluripotent 
stem cells, trans differentiation technologies for deriving neurons from adult humans, 
Vadodaria et al., 2018). However, they are insufficient to fully understand the pathways and 
progression of complex disorders. Some authors assert that systems biology might be the 
answer as it can integrate and model different levels of human experimental data – molecular, 
cellular, tissue, organ, clinical and population disorders (Langley, 2014). Others suggest a mind-
brain paradigm that combines simultaneous use of imaging techniques with the use of scales 
and/or other tests validated for psychodiagnostics as a way to build a bridge between 
neuroscience and psychological sciences to study mental disorders (Stoyanov, 2009). Others 
claim that the only way to overcome such limitations is resorting to animal models, which are 
seen by some as crucial for MDD research (e.g., Akil et al., 2018; Wang et al., 2017), despite 
their well-recognized limitations with respect to human predictively (Akil et al., 2018). 
To overcome these limitations, combinations of different animal models are proposed 
(Akil et al., 2018), different transgenic lines of rats are generated (Bailey, 2019) and efforts are 
made to overcome the biological differences between species that keep emerging as 
extrapolation barriers (Hodge et al., 2019). All the above involve high economic costs and 
consume a tremendous amount of animal lives. The reason behind this is because it is assumed 
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that animal use is unavoidable and its withdraw would jeopardize human health. However, very 
few studies have addressed the contribution of animal models to MDD research through 
significant critical scrutiny within peer-reviewed literature. Specifically, to our knowledge, the 
contribution of rats for this aim has never been evaluated in such terms, even though rodents 
are undoubtedly the most frequently used animals regarding this context. Even though mice are 
by far the most used rodents in biomedical research an initial search in PubMed, a search engine 
that comprises more than 30 million papers for biomedical literature, indicated that species 
within genus Rattus were highly used in MDD research, which made them an interesting case 
study. To evaluate the contribution of animal models to MDD research is important for ethical 
and economic reasons. As a society, we should make an informed decision on whether we 
should proceed refining animal models until we find a suitable one or if we should halt the 
current paradigm and invest more in other methods that might be more promising as well as 
cheaper and less ethically contentious (Carvalho et al., 2019). 
To conduct such evaluation, we performed a citation analysis on original publications 
describing rat data within MDD research. A citation analysis as defined by Garfield & Merton 
(1979) consists in determining the number of citations target papers (in this case original papers 
using rat models to study MDD) receive as well as determining citation patterns- in this case 
which sort of papers are citing the target papers (e.g. animal research papers, human research 
papers, review papers).  Granting that the studies cited guide and influence authors work 
(Burright et al., 2005) and that citation level has been related to clinical relevance in the past 
(Pound & Nicol, 2018), such citation analysis can be used as an indicator to evaluate the 
contribution of rat studies to current clinical knowledge in MDD, as has been done for other 
disorders (e.g., Carvalho et al., 2016; Knight, 2007; Long et al., 2014) as well as for other 
species in regard to MDD research (Carvalho et al., 2019). 
8 
This is an accepted manuscript of an article published by Frontiers Media in Frontiers in Psychology, 
available online at https://www.frontiersin.org/articles/10.3389/fpsyg.2020.01486/abstract. It is not the copy of 
record. Copyright © 2020, The Authors 
 
If rat studies are informing the human medical research community, then we expect that: 
1. Most of the papers would be cited at least once in subsequent human medical papers; 
2. The proportion of citations by human medical papers would be substantially higher 
when compared to other research categories. 
Methods 
The citation analysis was performed between January and August of 2019. PubMed and 
SCOPUS were searched for publications using rat models to investigate MDD. We searched 
PubMed using Medical Subject Heading search terms (MeSH terms): “Depressive Disorder, 
Major” AND “rat” OR “rodent”. MeSH terms are a comprehensive list of key terms made 
available by PubMed designed to identify all relevant studies in an area (Uman, 2011). So, 
searching for “Major Depressive Disorder” retrieves other nomenclatures for the same disorder 
such as melancholia. Similarly, the search term “rat” retrieves papers using all rat species. We 
used PubMed filters to exclude review articles (“review”, “systematic review”, “meta-
analysis”, “bibliography”) as well as opinion articles (“biography”, “auto-biography”, 
“comment”, “editorial”, “interview”). Since Scopus does not have the MeSH term tool we used 
the search terms “Major depressive disorder” AND (“rat” OR “rattus”) in the search fields. We 
included journal papers, books, research reports and conference proceedings written in English 
or Portuguese, which are within our language proficiency. We restricted our search to 
publications prior to December 31, 2013, to allow adequate time for citation of articles to occur. 
We did not include a lower date limit. 
Since our goal was to evaluate the contribution of animal models - particularly rat models- 
to current clinical knowledge of MDD, we excluded by hand from our analysis all the papers 
that reported animal and human data, as well as papers reporting other species’ data (e.g. mice). 
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Hence, we included only original papers focused on major depressive disorder, exclusively 
using data obtained from rats. We excluded papers describing other disorders, data from other 
species along with data from rats, and papers that did not present first hand data (e.g. review 
papers). Out of 237 papers originally located through the search engines’ filters, we excluded 
59 by hand because they met exclusion criteria.  
The retrieved papers were subjected to a subsequent citation analysis using the cited 
reference search facility within Scopus and Web of Science. 
Web of Science is a major scientific citation indexing service that encompasses over 
50,000 scholarly books, 12,000 journals and 160,000 conference proceedings. Scopus is the 
largest citation database; it covers nearly 36,377 titles from approximately 11,678 publishers. 
For each rat study, we recorded the total number of times it was cited, and allocated each 
citation to one or more of seven categories, defined prospectively: 
− Animals. This category included all animal studies from observational ethological 
studies to invasive procedures as defined by Knight (2011), i.e., interfering with bodily 
integrity (whether through puncture or incision) or production of genetically modified 
animals. This category also included severe procedures (as defined by current 
European Legislation Directive 2010/63/EU) commonly used in mental disorder 
research such as inescapable electroshock or isolating social animals for long periods.  
− Humans. This category included papers that used human participants. They included 
clinical or treatment trials (either drug trials or non-pharmacological treatments), 
papers aiming to explore psychological, social, biochemical, physiological, genetic or 
neurological variables related to MDD; as well as papers aiming to understand the 
relationship between MDD and other disorders (co-morbidities) in human patients 
10 
This is an accepted manuscript of an article published by Frontiers Media in Frontiers in Psychology, 
available online at https://www.frontiersin.org/articles/10.3389/fpsyg.2020.01486/abstract. It is not the copy of 
record. Copyright © 2020, The Authors 
 
− Reviews. This category included narrative reviews, systematic reviews, meta-analysis 
as well as extensive opinion papers that did not report original empirical data. We 
included reviews focused on animals and on humans alike. 
− Editorials. This category included editorials, comments and clinical guides. 
− In vitro. This category included exclusively cell-line data. Whenever the source of the 
tissue or cell was a human participant (either alive or post-mortem) or a laboratory 
animal killed for such purpose the paper was allocated into “human paper” or “animal 
research paper”, respectively. 
− In silico. This category included data obtained via computer simulations of human 
data.   
− Social. This category included human surveys or other social perception papers.  
Whenever it was not possible to define the category of the citing paper (due to language 
barriers – i.e. papers written in a language that was not English or Portuguese- or absence of 
the abstract), the paper was denoted “not available” and removed from the sample. If more than 
one category could be assigned to a citing paper (e.g., animal research and human paper), then 
that paper was allocated to every appropriate category. 
To evaluate if the proportions of citations made by human publications and animal 
publications on MDD were different we used a t-test. Results were considered statistically 
significant when P < 0.05. The analyses were performed in R 3.6.1 (R Core Team, 2019). 
Results 
The 178 original rat studies focused on MDD that were published before the end of 2013 
were cited 8,712 times by August, 2019. Of these 178, 87 (49%) studies were never cited in 
subsequent publications describing human studies on MDD, and 53 (30%) were never cited in 
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any publications related to human research, either focused on MDD, either on other disorders 
such as post-traumatic stress disorder or bipolar disorder. 
 As shown in Figure 1, rat studies were mainly cited by other animal research papers 
(4,641), followed by review papers (2,909), human studies (794), in vitro papers (211), 
editorials (58), in silico papers (57), and human social papers (one). 230 citations were 
unavailable to us due to access or language barrier. These were removed from further analysis. 
 
Figure 1. Frequency of citations by category established in this study  
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The proportion of citations by human medical papers is 9.1 % while the proportion of 
citations by animal papers is 53.3%. This corresponds to a mean difference between the 
proportions of citations by human and by animals of -46% (p<<0.001). Beyond the statistical 
significance, this is certainly a considerable practical difference that reflects almost 83% (100 
(9.1 – 53.3)/9.1)) less citations by human papers than by animal papers. 
 
Discussion 
The majority of the rat papers located in this study were cited by subsequent animal 
research papers, but about half (49%) of the original papers retrieved were never cited in 
subsequent papers related to MDD in humans, and in fact about a third (30%) were never cited 
in any subsequent human studies. 
Our citation analysis reveals that only around a tenth (9.1%) of the total number of 
citations were by human medical papers. This contradicts the hypothesis that citations made by 
human medical papers constitute a considerable proportion of the total number of citations, 
compared to the other categories, based on the assumption that animal models  and raises doubts 
about the justification for these studies. 
The results of our study are in agreement with previous studies that empirically evaluated 
the contribution of animal models to human healthcare either through citation analysis (e.g. 
Carvalho et al., 2016; Knight, 2007; Long et al., 2014; Shapiro, 1998) either through other 
methods such as systematic reviews (e.g. Perel et. al. 2007), social science studies (e.g. 
Compton et al., 2019; Shapiro, 1998), historical analysis (e.g. Menache, 2012), amongst others 
(for an extensive review on this topic see, for example, Knight, 2019).  
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 This suggests that, biomedical research resorting to animal models is not normally 
considered significant, or particularly visible to, the human medical research community.  
Supporters of animal models of human disorders claim that this happens: a) due to 
differences in the way basic animal work and human clinical trials are conducted, and propose 
a change to a translational biomarker-based approach within early steps of pre-clinical research 
(Garner, 2014); b) failings in study design, conduct, analysis and reporting (Pound & Ritskes-
Hoitinga, 2018), which could be resolved with better reporting and better methodological 
quality (Fabian-Jessing et al., 2018). 
Opponents of the use of animal models point out that animal models lack external validity 
i.e. findings derived in one setting, population or species cannot be reliably applied to other 
settings, populations and species, which is unavoidable since animal models: a) oversimplify 
complex human disorders and the conditions in which they occur (Stoyanov, 2009; Pound & 
Ritskes-Hoitinga, 2018).; b) are unsuitable models due to species differences, proposing as a 
possible solution a shift towards human-based non-clinical research (Pound & Ritskes-
Hoitinga, 2018). 
This paradigm change towards human-based research is gaining more and more 
supporters both for ethical and scientific reasons (e.g., LaFollette & Shanks, 1995). Langley, 
2014; Pound & Ritskes-Hoitinga, 2018; Ram, 2019). But the resistance from animal researchers 
in face of this shift remains significant and is evident not only in the slowness to recognize the 
growing body of evidence against the use of animals as models, but also in the emphasis placed 
on refinement of animal use (Franco & Olsson, 2014) (the third R as defined by Russel and 
Burch (1959), instead of on the first and most important R – replacement with non-animal 
alternatives). Considering this, Frank (2005) proposed that animal experimentation constitutes 
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a good example of path dependency, which is a well-documented phenomenon that states that 
what has occurred in the past persists because of resistance to change. 
Our results also show that more than half (53%) of the citations our target papers received 
were by subsequent animal papers, which strengthens the idea of the path dependency 
phenomenon described above. It can be argued that there is a need to have a substantial amount 
of animal research before achieving a critical mass that can lead to useful breakthroughs in 
human health, which might explain the high level of citations of animal papers by subsequent 
animal papers. Nonetheless, it does not explain the low level of citations by human papers, 
especially when this does not appear to be a trend in human-based approaches (in vitro and in 
silico) which received more citations by human medical papers in a small study previously 
conducted (Carvalho et al., 2019). Furthermore, a recent citations analysis in another field of 
human health research also found in vitro papers to be the most cited papers, above reviews and 
animal experimentations papers (Adnan & Ullah, 2018). 
We acknowledge that this study has certain limitations. Even though we used two big 
bibliographic databases to attempt to locate all publications that met our search criteria, we 
acknowledge that a small minority of relevant papers may not have been retrieved (e.g. due to 
labelling errors).  
Similarly, we did not take note of certain citations such as self-citations, in-house citations 
(i.e. citations from colleagues of the same lab) and content-irrelevant citations (e.g. the paper is 
cited for other reasons aside from its content). Such citation types were not considered 
significant in several studies and were similarly dismissed in recent studies (Huang et al., 2019).  
Also, we did not analyze the quality of citing papers as in previous studies (Carvalho et 
al., 2016; Carvalho et al., 2019). This might have resulted in an even lower, but a truer, 
indication of the contribution of rat models for current clinical  knowledge of MDD. 
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Finally, we acknowledge that being cited by human medical papers is not the only 
indicator of the clinical usefulness of research. Uncited studies may also contribute, for 
example, through direct transfer of knowledge between scientists and clinicians. Most clinicians 
are not involved in research, i.e., they do not publish, hence it is possible that practitioners 
involved in the treatment of MMD are informed by or utilize findings from the rat studies 
through direct transfer of knowledge. A citation analysis does not measure this effect. However, 
it is also possible that clinicians are less aware of research results, than researchers. Thus, a 
survey on practitioners – which we did not perform- would have been an interesting 
complement to our results. 
Review papers on depression that might inspire authors likely cite animal papers, 
nonetheless if the animal paper is really relevant for the authors hypothesis or method the 
chances are the primary paper will be cited and not the review paper that referred to it.  
Citation rates may also be affected by factors such as article length, number of authors, 
their country and university of affiliation (Leimu & Koricheva, 2005). Despite their limitations 
however, citation frequencies do normally provide reasonably objective approximation of the 
importance of research results within a field. Research that makes a significant contribution—
such as by confirming or refuting important hypotheses—is likely to be cited by subsequent 
papers. Research that is inconclusive or lacking in significance is much less likely to be cited.  
 
Accordingly, we believe that our citation analysis provides a valid and critical assessment 
of the contribution of rat models to current clinical knowledge of MDD. Such evaluation of the 
efficacy of research approaches is important to ensure the most responsible allocation of 
research funds and scientific resources, to maximize the likelihood of clinical benefit to 
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patients, and to minimize the consumption of animal lives in research where such benefits are 
unlikely. 
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